Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens.

aminoglycosides gram-negative infections multidrug-resistant nebulization pharmacokinetics toxicity

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
06 May 2023
Historique:
received: 30 03 2023
revised: 01 05 2023
accepted: 04 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active against resistant Gram-negative bacterial infections. Over the past decade, their use in critically ill patients has been refined; however, due to their renal and cochleovestibular toxicity, their indications in the treatment of sepsis and septic shock have been gradually reduced. This article reviews the spectrum of activity, mode of action, and methods for optimizing the efficacy of aminoglycosides. We discuss the current indications for aminoglycosides, with an emphasis on multidrug-resistant Gram-negative bacteria, such as extended-spectrum β-lactamase-producing

Identifiants

pubmed: 37237763
pii: antibiotics12050860
doi: 10.3390/antibiotics12050860
pmc: PMC10215420
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Crit Care Med. 2009 Mar;37(3):840-51; quiz 859
pubmed: 19237886
Clin Infect Dis. 2013 Aug;57(3):349-58
pubmed: 23616495
Int J Antimicrob Agents. 2011 Jun;37(6):491-503
pubmed: 21292449
J Infect Dis. 1987 Jan;155(1):93-9
pubmed: 3540140
BMJ. 1996 Feb 10;312(7027):338-45
pubmed: 8611830
Antimicrob Agents Chemother. 2014 Sep;58(9):5598-601
pubmed: 24982065
J Antimicrob Chemother. 2017 Jan;72(1):29-39
pubmed: 27624572
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4901-9
pubmed: 27270279
Clin Infect Dis. 2005 Jul 15;41(2):149-58
pubmed: 15983909
Int J Antimicrob Agents. 2019 Feb;53(2):152-157
pubmed: 30722960
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5208-14
pubmed: 27297487
Antimicrob Agents Chemother. 2015 Sep;59(9):5834-7
pubmed: 26124174
Curr Drug Targets. 2002 Aug;3(4):335-44
pubmed: 12102603
Antimicrob Agents Chemother. 2014;58(4):2322-8
pubmed: 24514083
Int J Antimicrob Agents. 2016 Dec;48(6):647-654
pubmed: 27746102
Antimicrob Agents Chemother. 1984 Oct;26(4):535-8
pubmed: 6517544
Clin Infect Dis. 2010 Jul 1;51(1):79-84
pubmed: 20504234
Lancet Infect Dis. 2017 Jul;17(7):726-734
pubmed: 28442293
Indian J Crit Care Med. 2018 Feb;22(2):67-77
pubmed: 29531445
ACS Infect Dis. 2017 Mar 10;3(3):206-215
pubmed: 28103015
Curr Opin Infect Dis. 2022 Apr 1;35(2):170-175
pubmed: 35044973
Crit Care. 2018 Nov 15;22(1):301
pubmed: 30442203
Int J Antimicrob Agents. 2023 Feb;61(2):106707
pubmed: 36608719
Clin Infect Dis. 2021 Apr 8;72(7):e169-e183
pubmed: 33106864
Br Med J. 1974 Sep 28;3(5934):778-80
pubmed: 4213265
Clin Infect Dis. 2020 Feb 3;70(4):704-709
pubmed: 31328228
Crit Care Med. 2003 Aug;31(8):2102-6
pubmed: 12973166
J Antimicrob Chemother. 1988 Jul;22(1):23-33
pubmed: 3139614
BMJ. 2012 Sep 27;345:e6354
pubmed: 23044986
N Engl J Med. 2019 Feb 21;380(8):791-793
pubmed: 30786196
Antimicrob Agents Chemother (Bethesda). 1963;161:1-7
pubmed: 14274893
Clin Microbiol Infect. 2022 Apr;28(4):521-547
pubmed: 34923128
Clin Microbiol Infect. 2018 Dec;24(12):1315-1321
pubmed: 29581056
Lancet Infect Dis. 2020 Mar;20(3):330-340
pubmed: 31866328
J Clin Pharmacol. 2010 Aug;50(8):922-8
pubmed: 20035039
Intensive Care Med. 2020 Mar;46(3):546-548
pubmed: 31974920
Biochim Biophys Acta. 2009 May;1794(5):769-81
pubmed: 19026770
Dtsch Arztebl Int. 2018 May 21;115(20-21):345-352
pubmed: 29914612
Lancet Infect Dis. 2018 Apr;18(4):391-400
pubmed: 29456043
Pharmacotherapy. 2017 Nov;37(11):1415-1431
pubmed: 28869666
Antimicrob Agents Chemother. 1982 Nov;22(5):743-52
pubmed: 7181485
Infect Dis Clin North Am. 2016 Jun;30(2):523-537
pubmed: 27208771
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Antimicrob Chemother. 2015 Jul;70(7):2133-43
pubmed: 25900159
Clin Pharmacokinet. 2007;46(12):997-1038
pubmed: 18027987
J Infect. 2017 Apr;74(4):331-344
pubmed: 27919645
Chin Med J (Engl). 2017 May 20;130(10):1196-1201
pubmed: 28485320
Clin Infect Dis. 2005 Nov 15;41(10):1542-3; author reply 1543-4
pubmed: 16231273
Intensive Care Med. 2020 Jun;46(6):1127-1153
pubmed: 32383061
Chest. 2017 Jun;151(6):1239-1246
pubmed: 27890714
Expert Rev Anti Infect Ther. 2022 Jul;20(7):963-979
pubmed: 35385681
J Clin Med Res. 2011 May 19;3(3):106-10
pubmed: 21811540
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):755-765
pubmed: 30680569
Epidemiol Infect. 2013 Jun;141(6):1214-22
pubmed: 22954403
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3187-92
pubmed: 26926642
Front Cell Infect Microbiol. 2019 Dec 10;9:422
pubmed: 31921701
Clin Infect Dis. 2012 Oct;55(7):943-50
pubmed: 22752516
Antimicrob Agents Chemother. 1974 Oct;6(4):442-6
pubmed: 4157342
Antimicrob Agents Chemother. 2013 Feb;57(2):977-82
pubmed: 23229487
Int J Antimicrob Agents. 2016 Apr;47(4):317-23
pubmed: 27020541
J Antimicrob Chemother. 2016 Jan;71(1):208-12
pubmed: 26429564
Crit Care Med. 2010 Aug;38(8):1651-64
pubmed: 20562695
Clin Microbiol Infect. 2016 May;22(5):444-50
pubmed: 26850826
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29866876
J Antimicrob Chemother. 2021 Jul 15;76(8):2097-2105
pubmed: 33860309
Intensive Care Med. 2021 Nov;47(11):1181-1247
pubmed: 34599691
Drug Resist Updat. 2010 Dec;13(6):151-71
pubmed: 20833577
Crit Care. 2010;14(2):R53
pubmed: 20370907
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2275-2281
pubmed: 31478103
Antimicrob Agents Chemother. 1999 Mar;43(3):623-9
pubmed: 10049277
Clin Microbiol Rev. 2012 Jul;25(3):450-70
pubmed: 22763634
Sci Rep. 2021 Mar 26;11(1):6969
pubmed: 33772055
Int J Antimicrob Agents. 2020 Jul;56(1):106019
pubmed: 32422315
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
Clin Ther. 2021 Jun;43(6):1125-1131
pubmed: 34108081
Intensive Care Med. 2014 Jul;40(7):998-1005
pubmed: 24687298
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Life (Basel). 2022 Nov 22;12(12):
pubmed: 36556314
Chest. 2005 Aug;128(2):545-52
pubmed: 16100136
Clin Pharmacokinet. 1994 Nov;27(5):377-92
pubmed: 7851055
Cochrane Database Syst Rev. 2014 Jan 07;(1):CD003344
pubmed: 24395715
Clin Microbiol Infect. 2018 Dec;24(12):1231-1233
pubmed: 30076976
Antibiotics (Basel). 2021 Apr 29;10(5):
pubmed: 33946905
Int J Clin Pharmacol Ther. 1997 Jun;35(6):223-6
pubmed: 9208335
Int J Antimicrob Agents. 2018 Apr;51(4):535-547
pubmed: 29288723
J Antimicrob Chemother. 2015 Apr;70(4):1203-11
pubmed: 25492391
J Infect Dis. 2008 Apr 15;197(8):1079-81
pubmed: 18419525
Clin Orthop Relat Res. 2005 Aug;(437):3-6
pubmed: 16056018
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29866862
Antibiotics (Basel). 2022 Dec 09;11(12):
pubmed: 36551445
Ann Intensive Care. 2021 Mar 19;11(1):49
pubmed: 33740157
Ann Intensive Care. 2021 Nov 26;11(1):160
pubmed: 34825962
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0004521
pubmed: 33972253
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30397061
J Chromatogr B Biomed Sci Appl. 2000 Sep 29;747(1-2):69-93
pubmed: 11103900
Clin J Am Soc Nephrol. 2008 Mar;3(2):355-61
pubmed: 18235142
Clin Infect Dis. 2015 Jun 1;60(11):1622-30
pubmed: 25694654
Crit Care Med. 2010 Sep;38(9):1773-85
pubmed: 20639750
ACS Chem Biol. 2013 Jan 18;8(1):105-15
pubmed: 23110460
Ann Clin Microbiol Antimicrob. 2016 Jun 17;15(1):39
pubmed: 27316973

Auteurs

Michaël Thy (M)

Assistance Publique Hôpitaux de Paris (AP-HP), Service de Médecine Intensive et Réanimation Infectieuse, Hôpital Bichat Claude-Bernard, Université Paris Cité, 46 Rue Henri Huchard, 75018 Paris, France.
Equipe d'accueil (EA) 7323, Department of Pharmacology and Therapeutic Evaluation in Children and Pregnant Women, Université Paris Cité, 75018 Paris, France.

Jean-François Timsit (JF)

Assistance Publique Hôpitaux de Paris (AP-HP), Service de Médecine Intensive et Réanimation Infectieuse, Hôpital Bichat Claude-Bernard, Université Paris Cité, 46 Rue Henri Huchard, 75018 Paris, France.
Unité mixte de Recherche (UMR) 1137, Infection, Antimicrobials, Modelization, Epidemiology (IAME), Institut National de la Recherche Médicale (INSERM), Université Paris Cité, 75018 Paris, France.

Etienne de Montmollin (E)

Assistance Publique Hôpitaux de Paris (AP-HP), Service de Médecine Intensive et Réanimation Infectieuse, Hôpital Bichat Claude-Bernard, Université Paris Cité, 46 Rue Henri Huchard, 75018 Paris, France.
Unité mixte de Recherche (UMR) 1137, Infection, Antimicrobials, Modelization, Epidemiology (IAME), Institut National de la Recherche Médicale (INSERM), Université Paris Cité, 75018 Paris, France.

Classifications MeSH